About 6,753 results

ALLMedicine™ Rubella Center

Research & Reviews  1,959 results

Mystery of fatal 'staggering disease' unravelled: novel rustrela virus causes severe me...
Nature Communications; Matiasek K, Pfaff F et. al.

Feb 5th, 2023 - 'Staggering disease' is a neurological disease entity considered a threat to European domestic cats (Felis catus) for almost five decades. However, its aetiology has remained obscure. Rustrela virus (RusV), a relative of rubella virus, has recentl...

Vaccine Responses in Congenital Cytomegalovirus Infection.
The Pediatric Infectious Disease Journal; Kokkola E, Puhakka L et. al.

Feb 3rd, 2023 - There is limited information on vaccine responses in children with congenital cytomegalovirus infection (cCMV). We studied diphtheria, tetanus, measles, mumps and rubella vaccine responses in 6-year-old children with cCMV and controls. Protective ...

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Jan 30th, 2023 - This study is a prospective, randomized trial. The target population is all patients between the ages of 2 and 21 years of age who complete cancer directed systemic therapy for any malignant diagnosis at our center over a 2 to 3-year time frame. T...

Shedding of rubella virus in postsymptomatic individuals; viral RNA load is a potential...
Journal of Clinical Virology : the Official Publication O... Kanbayashi D, Kurata T et. al.

Jan 23rd, 2023 - Since the first isolation of rubella virus (RuV) in 1962, comprehensive data regarding the quantitative evaluation of RuV shedding remain unavailable. In this study, we evaluated the shedding of viral RNA and infectious virus in patients with acut...

Developmental Outcomes in Children Born to Women with Possible Subclinical Rubella Expo...
Journal of Medical Virology; Hutton J

Jan 22nd, 2023 - This study investigated outcomes of children born to women who seroconverted to rubella immune during pregnancy. In a prior 2012-2013 study of 296 women who were rubella non-immune, 26 (8.8%) seroconverted to rubella immune during pregnancy. These...

see more →

Guidelines  6 results

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on...
MMWR. Morbidity and Mortality Weekly Report; Krow-Lucal E, Marin M et. al.

Nov 18th, 2022 - Vaccination is the main means for preventing measles, mumps, and rubella virus infections and their related complications (1,2). Achieving and maintaining high 2-dose measles, mumps, and rubella vaccination coverage in the United States has led to...

The Need to Optimize Adolescent Immunization.
Pediatrics Bernstein HH, Bocchini JA et. al.

Feb 9th, 2017 - The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of t...

Toxoplasmosis in pregnancy: prevention, screening, and treatment.
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Paquet C, Yudin MH et. al.

Jan 25th, 2013 - One of the major consequences of pregnant women becoming infected by Toxoplasma gondii is vertical transmission to the fetus. Although rare, congenital toxoplasmosis can cause severe neurological or ocular disease (leading to blindness), as well a...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Rubella vaccines: WHO position paper--recommendations.
Vaccine Who Publication

Sep 21st, 2011 - Rubella vaccines: WHO position paper--recommendations.|2011|Who Publication ,|prevention & control,administration & dosage,

see more →

Drugs  16 results see all →

Clinicaltrials.gov  133 results

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Jan 30th, 2023 - This study is a prospective, randomized trial. The target population is all patients between the ages of 2 and 21 years of age who complete cancer directed systemic therapy for any malignant diagnosis at our center over a 2 to 3-year time frame. T...

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Jan 18th, 2023 - The main purpose of this study is to assess immune response and safety of various potencies of a measles, mumps, rubella, and varicella (MMRVNS) vaccines given to healthy children of 4 to 6 years of age.

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Jan 17th, 2023 - This trial has six groups. This will be a double-blind, individually randomised trial, with 1:1 randomisation with the single or two vial presentation of R21/Matrix-M malaria vaccine for study groups 1, 2 and 3. Groups 1, 2 and 3 are to assess the...

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Dec 12th, 2022 - Yellow fever (YF) continues to be a public health problem for 13 countries in the Americas, including northern Argentina. From 1960 to 2019, these countries reported 9,673 confirmed cases and 2,480 deaths. In the same period, Argentina reported 69...

Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple Sclerosis

Nov 16th, 2022 - Disease prevention is a set of "specific, population-based and individual-based interventions for primary and secondary (early detection) prevention, aiming to minimize the burden of diseases and associated risk factors.". Depending on the objecti...

see more →

News  552 results

Routine Vaccinations Continue to Decline Among Kindergartners

Jan 12th, 2023 - Routine childhood vaccinations among kindergartners declined in the 2021-2022 school year, contributing to a 2-percentage point decrease in vaccine coverage in this age group since the start of the COVID-19 pandemic, CDC researchers found. Among a...

Ohio Measles Outbreak Jumps to 74 Cases

Dec 13th, 2022 - Measles cases continue to rise in central Ohio, with total cases hitting 74 this week, up from about 50 reported last week, according to Columbus Public Health. Of the 74 reported cases, all have occurred in children and adolescents, with 69 cases...

Measles in the US: 5 Things You Need to Know

Dec 13th, 2022 - 1. Measles is circulating, and undervaccinated communities are at risk. While overall childhood vaccination rates remain high in the United States, measles cases still occur here. Measles is easily imported by unvaccinated travelers and can spread...

Ohio Measles Outbreak Sickens Nearly 60 Children

Dec 7th, 2022 - Measles has sickened 59 children in an outbreak that began in November and now spans four Ohio counties. None of the children had been fully vaccinated against measles, and 23 of them have been hospitalized, local officials report. "Measles can be...

How well are we doing with adolescent vaccination?
MDedge Family Medicine; Doug Campos-Outcalt, MD, MPA

Sep 28th, 2022 - Every year, the Centers for Disease Control and Prevention (CDC) conducts a national survey to provide an estimate of vaccination rates among adolescents ages 13 to 17 years. The results for 2021, published recently, illustrate the progress that w.

see more →

Patient Education  35 results see all →